MedPath

Dietary Reporting in the Amyloidoses

Not Applicable
Recruiting
Conditions
Amyloidosis
Interventions
Other: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Registration Number
NCT05738005
Lead Sponsor
Barbara Ann Karmanos Cancer Institute
Brief Summary

The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.

The main question it aims to answer is:

Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients

Participants will be asked to:

* Download the MyFitnessPal application on their smartphone and view an online tutorial

* After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone.

* complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 18 years of age or older
  • Diagnosed with any type of amyloidosis
  • Speak, read and write in English
  • Willing to use the MyFitnessPal app on their own smartphone
Exclusion Criteria
  • a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
  • cognitive or perceptual disturbances

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)MyFitnessPal smartphone application is used to track daily dietary intake and herbal/alternative supplements.
Primary Outcome Measures
NameTimeMethod
Adherence Rate56 days

The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.

Secondary Outcome Measures
NameTimeMethod
Subsequent adherence rate63 days (= 56 days + Week 10)

The subsequent adherence is the status of data recording per day during the third phase (Week 10) of trial participation (i.e., 7 days); The subsequent adherence rate will be calculated by the ratio of the number of days of adherence during the third phase (Week 10) of trial participation (i.e., 7 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.

Trial Locations

Locations (1)

Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath